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ABSTRACT
Yeast carries a strictly conserved branch point
sequence (BPS) of UACUAAC, whereas the human
BPS is degenerative and is less well characterized.
The human consensus BPS has never been exten-
sively explored in vitro to date. Here, we sequenced
367 clones of lariat RT-PCR products arising from
52 introns of 20 human housekeeping genes. Among
the 367 clones, a misincorporated nucleotide at the
branch point was observed in 181 clones, for which
we can precisely pinpoint the branch point. The
branch points were comprised of 92.3% A, 3.3% C,
1.7% G and 2.8% U. Our analysis revealed that the
human consensus BPS is simply yUnAy, where the
underlined is the branch point at position zero and
the lowercase pyrimidines (‘y’) are not as well
conserved as the uppercase U and A. We found
that the branch points are located 21–34 nucleotides
upstream of the 3’ end of an intron in 83% clones.
We also found that the polypyrimidine tract spans
4–24 nucleotides downstream of the branch point.
Our analysis demonstrates that the human BPSs
are more degenerative than we have expected and
that the human BPSs are likely to be recognized in
combination with the polypyrimidine tract and/or
the other splicing cis-elements.
INTRODUCTION
In higher eukaryotes, pre-mRNA splicing is mediated by
degenerative splicing cis-elements comprised of the branch
point sequence (BPS), the polypyrimidine tract (PPT), the
50 and 30 splice sites and exonic/intronic splicing enhanc-
ers/silencers. Stepwise assembly of the spliceosome starts
from recruitment of U1 snRNP, SF1, U2AF65 and
U2AF35 to the 50 splice site, the branch site, the PPT
and the 30 end of an intron, respectively (Complex E). SF1,
a 75-kDa polypeptide, is a mammalian homolog of
yeast BBP (branch point-binding protein). U2AF65 and
U2AF35 bring U2snRNP to the BPS in place of SF1 (1,2).
The BPS establishes base pairing interactions with a
stretch of ‘GUAGUA’ of U2 snRNA (3,4), which then
bulges out the branch site nucleotide, usually an adenosine
(Complex A) (5). Thereafter, pre-mRNAs are spliced in
two sequential transesteriﬁcation reactions mediated by
the spliceosome. In the ﬁrst step, the 20-OH moiety of the
branch site nucleotide carries out a nucleophilic attack
against a phosphate at the 50 splice site, generating a free
upstream exon, as well as a lariat carrying the intron and
the downstream exon. In the second step, the 30-OH
moiety of the upstream exon attacks the 30 splice site
leading to intron excision and ligation of the upstream and
downstream exons (6). The branch site is thus involved in
the ﬁrst step of splicing, and potentially in the second step
of splicing, although the detailed molecular mechanisms
of contribution to the second step remain elusive (7).
The BPS is strictly conserved in yeast and has the
sequence of UACUAAC, where the branch point adeno-
sine is underlined. On the other hand, the human BPSs are
degenerative. No extensive in vitro identiﬁcation of human
BPSs has been reported. Five communications address the
mammalian consensus BPSs (Table 1). Three reports are
based on 11–20 in vitro identiﬁed BPSs, and two are
dependent on the in silico analysis of the human genome.
In an eﬀort to establish the human consensus BPS based
on in vitro experiments, we analyzed 367 clones of lariat
RT-PCR products arising from 52 introns of 20 human
housekeeping genes. We found that the human consensus
BPS is yUnAy. Our analysis demonstrates that the human
BPSs are more degenerative than we have expected and
that the BPS is likely recognized in combination with the
PPT and/or the other splicing cis-elements.
MATERIALS AND METHODS
Lariat RT-PCR primers forhuman housekeeping genes
Among the 575 human housekeeping genes registered
at http://www.compugen.co.il/supp_info/Housekeeping_
genes.html (8), we excluded 82 genes, for which we
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NCBI UniGene database (http://www.ncbi.nlm.nih.gov/
UniGene/). Among 4188 introns of the remaining 493
human housekeeping genes, we excluded introns with a
size of less than 300 nucleotides or with multiple repeated
segments, because it was diﬃcult to design appropriate
PCR primers for such introns. We next sorted the 493
genes in the order of skin expression levels according to
the EST proﬁle viewer, and picked up the 20 best genes.
We thus analyzed 52 introns of the 20 human house-
keeping genes (Supplementary Table 1).
We placed the sense primers at least 100 nucleotides
upstream of the 30 end of an intron, and the antisense
primers at least 10 nucleotides downstream of the 50 end of
an intron. The melting temperatures of the primers were
designed to be 64–678C according to the nearest neighbor
method. Gene symbols, intron numbers and primer
sequences are indicated in Supplementary Table 1.
Lariat RT-PCRto identify thebranch point
We performed nested lariat RT-PCR to amplify a frag-
ment spanning the 20–50 phosphodiester bond at the branch
point (9). We isolated total RNA from HEK293 cells
grown to conﬂuency in DMEM medium (Sigma-Aldrich)
supplemented with 10% fetal bovine serum (Sigma-
Aldrich) and penicillin–streptomycin (Invitrogen). First-
strand cDNA was synthesized with SuperScript II reverse
transcriptase (Invitrogen) using an intron-speciﬁc anti-
sense primer C (Figure 1) located close to the 50 end of an
intron. The ﬁrst round of lariat RT-PCR was performed
using primers C and D with Taq HS DNA polymerase
(Takara) in 25ml. The nested lariat RT-PCR was carried
out with primers A and B using 0.2ml of the ﬁrst-round
lariat RT-PCR product in 50ml. The ﬁrst-round PCR
program was comprised of an initial denaturation step at
948C for 3min, followed by 30 cycles of 948C for 30s, 558C
for 30s and 728C for 1min. For the nested PCR, we
performed 35 cycles of ampliﬁcation.
We puriﬁed the nested lariat RT-PCR products using
the Wizard SV Gel and PCR Clean-up system (Promega),
andcloned them intothe pGEM-T-Easy vector (Promega).
We sequenced 10 clones for each intron using theCEQ8000
genetic analyzer (Beckman Coulter).
Presentations ofsequence motifs
Sequence motifs are presented using the Pictogram web
server at http://genes.mit.edu/pictogram.html (10).
To indicate the amount of information conferred
by each nucleotide at each position, we employed
the WebLogo program at http://weblogo.berkeley.edu/
(11,12). We also calculated the total amount of informa-
tion content at each position using the following formula:
Rsequence ¼ 2 þ
X
Pilog2 Pi i ¼ A,C,GandU ðÞ
where Pi represents the probability of nucleotide i at each
position. Rsequence represents the degree of conservation
Figure 1. (A) Lariat RT-PCR of PGK1 intron 6 indicates a
misincorporated ‘A’ nucleotide at the branch point. We can pinpoint
the branch point in this situation. The sequencing is performed with
primer B. The small dots indicate the 50 end of an intron. (B) Lariat
RT-PCR of GAPDH intron 2 exhibits no misincorporated nucleotide.
The branch point can be either at ‘C’ or upstream ‘T’ depending on
whether skipping of the reverse transcriptase occurs or not. We cannot
locate the exact branch point in this case. The sequencing is performed
with primer A.
Table 1. Previously reported consensus BPSs
Consensus BPS Note References
S. cerevisiae
UACUAAC Invariant BPS (36,37)
Mammals
YNYURAY 11 mammalian BPSs (25)
YNCURAC 20 mammalian BPSs (38)
YNCURAY 15 BPSs of human HBB (39)
CURAY In silico homology search (40)
YUVAY
a
CUSAY
b
In silico homology search (41)
Branch point ‘A’ is underlined.
Y, U or C; R, A or G; S, G or C; V, A, C or G.
aLow GC% region.
bHigh GC% region.
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2.0 when a single nucleotide is exclusively observed at
a speciﬁc position, whereas it becomes 0.0 when four
nucleotides are evenly observed.
RESULTS
Collation of previously identified mammalian BPSs
As shown in Table 1, ﬁve communications address the
mammalian consensus BPSs. In order to understand the
in vitro determined mammalian consensus BPS, we collated
29 previously reported BPSs comprised of 25 mammalian
and four viral introns (Table 2). Viral introns should be
spliced in the same way as the mammalian genes. The
branch points are located between positions  38 to  4
(mean and SD,  26.9 7.8). Nucleotides ‘C’, ‘U’, ‘A’ and
‘Y’ at positions  3,  2, 0 and +1 are observed at 21
(72.4%), 21 (72.4%), 23 (79.3%) and 25 sites (86.2%),
respectively. The deduced consensus BPS thus becomes
CUnAy at positions  3 to +1 (Figure 2A and B), when we
arbitrarily assume that positions with the information
contents above 0.45 are signiﬁcant.
Lariat RT-PCR withor without amisincorporated
nucleotide at thebranchpoint
To further explore the human consensus BPS, we chose 52
introns of 20 human housekeeping genes. We performed
nested lariat RT-PCR and cloned the ampliﬁed products.
We sequenced ten clones from each intron, and 367 clones
carried available inserts, which represented 117 possible
branch sites (Table 3). The remaining 153 clones carried
either no inserts or PCR artifacts.
The 367 clones were divided into two classes: 181 clones
carrying misincorporated nucleotides at the branch points,
and 186 clones without misincorporated nucleotides. For
those carrying misincorporated nucleotides, we could
pinpoint the exact branch points (Figure 1A). On the
other hand, for those carrying no misincorporated
nucleotides, the reverse transcriptase might have skipped
one or two nucleotides at the 20–50 phosphodiester bond at
the branch points (Figure 1B).
Among the 367 clones, we observed two or more
possible branch sites in 36 of 52 introns. The 36 introns
carried a total of 101 possible branch sites. Among the 101
sites, 25 were followed by an immediate downstream
branch site, making 25 possible branch-site pairs. Among
the 25 upstream branch sites, 19 carried no misincorpo-
rated nucleotides. In addition, 13 of the 19 upstream sites
were followed by an ‘A’ nucleotide. Furthermore, when
we simply deduced the consensus BPS from all 367 clones,
the consensus BPS became more degenerative and less
informative (data not shown). These ﬁndings suggest that
the observed upstream branch points are likely due to
skipping of a nucleotide in lariat RT-PCR. We thus
employed the 181 clones carrying misincorporated nucleo-
tides at the branch points in the following analyses unless
otherwise stated.
Table 2. Previously identiﬁed mammalian and viral BPSs
Species Gene Intron BPS Position Predicted BP
a BPS Score
a Reference
H. sapiens CALCA 4 CACTCAC  36
b  36A 3.85 (42)
H. sapiens CALCA 3 TACTGTC  23
b  42A 2.60 (21)
H. sapiens CALCA 3 GTACTGT  24
b  42A 2.60 (21)
H. sapiens CALCA 3 GGTGCAT  32
b  42A 2.60 (21)
H. sapiens CSH1 1 CCTCCAT  23
b  23A 2.75 (22)
H. sapiens DQB1 3 CACAGAC  21
c  21A 3.25 (17)
H. sapiens GH1 1 CTCTGTT  22
b na na (22)
H. sapiens GH1 1 GGCTCCC  28
b na na (22)
H. sapiens GH1 1 TGCTCTC  36
b na na (22)
H. sapiens GH1 4 GCCTCTC  24
b  37A 2.80 (22)
H. sapiens GH1 4 ACCCAAG  37
b  37A 2.80 (22)
H. sapiens GH1 4 TACCCAA  38
b  37A 2.80 (22)
H. sapiens HBA 1 CCCTCAC  19
b  37A 3.25 (25)
H. sapiens HBA 2 CACTGAC  18
b  18A 3.95 (25)
H. sapiens HBB 1 CACTGAC  37
b  37A 3.95 (25)
H. sapiens HBE1 1 CTCTAAT  31
b  31A 3.45 (25)
H. sapiens HBG1 1 TTCTGAC  30
b  30A 3.85 (25)
H. sapiens MYH10 5 TGCTAAC  31
b na na (15)
H. sapiens XPC 3 TGTTGAT  4
b na na (16)
H. sapiens XPC 3 TACTGAT  24
b na na (16)
M. musculus Hbb-b2 1 CACTAAC  36
b  36A 3.85 (25)
M. musculus Igh 5 AATTCAC  22
b  22A 3.30 (14)
R. norvesicus Ins1 1 CCTCAAC  18
b  18A 3.15 (25)
O. cuniculus Hbb 1 TGCTGAC  34
b  34A 3.85 (25)
O. cuniculus Hbb 2 TGCTAAC  32
b  32A 3.75 (28)
Adenovirus 5 E1A 1 GTTTAAA  30
b  30A 2.70 (25)
Adenovirus 2 E2a-2 1 GACTGAC  26
b  26A 3.70 (42)
Adenovirus 5 Major Late 1 TACTTAT  24
b  24A 3.05 (42)
SV40 T antigen 1 ATTCTAA  19
b  19A 2.00 (42)
aPredicted BPs and BPS scores are according to the Branch-Site Analyzer at http://ast.bioinfo.tau.ac.il/BranchSite.htm (14). na, not available.
bIdentiﬁed by the primer extension method.
cIdentiﬁed by lariat RT-PCR.
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branch point in order to weigh the preferred branch
points. For example, in PGK1 intron 6, eight clones
mapped to ‘A’ at position  23, whereas one clone pointed
to ‘A’ at position  28 (Table 3). We assumed that the
branch point at position  23 was eight times more fre-
quently employed than that at position  28. This analysis
method might have overweighed introns that gave rise to
more clones. An alternative analysis method would be
to make the contribution of each intron equal regardless
of the number of available clones. The alternative method,
however, is also biased in favor of introns with fewer
clones. For example, PGK1 intron 8 had a single available
clone mapping to position  27, whereas EEF1A1 intron 1
had ten clones all mapping to position  23. A single clone
of PGK1 might have arisen from one of many branch
points, and we might have sequenced it by chance. On the
other hand, it is likely that EEF1A1 intron 1 indeed had
a single branch point. We analyzed our data using both
methods and obtained similar results (data not shown),
except that the frequency of C at position  1 was slightly
lower with the alternative method (44.8% versus 36.3%).
In the current communication, we employed the former
method, in which each clone was counted as a single
occurrence of a branch site.
Positions and sequence motif of thebranchpoints
Analysis of the 181 clones revealed that the positions of
the branch points were from  50 to  5, where position
 1 represents the 30 end of an intron (Figure 3A). Among
the 181 sites, 150 (83%) were at positions  34 to  21.
We observed U at position  2 in 74.6% branch sites,
and A at position 0 in 92.3% branch sites (Table 4).
In addition, pyrimidines were observed at positions  3
and +1 in 79.0% and 75.1% branch sites, respectively
(Table 4). We can thus conclude that the human consensus
BPS is yUnAy at positions  3 to +1 (Figure 2C), where
the branch site is underlined and the less conserved
nucleotides are indicated in lowercase letters. The infor-
mation contents of 0.27 and 0.23 at positions  3 and +1,
however, were not as high as those of 0.85 and 1.48
at positions  2 and 0 (Figure 2D), or 0.39 0.12
(mean SD) of the polypyrimidine tract at positions +4
to +24 (Figure 3C). Therefore, the consensus sequence
alternatively becomes UnA according to the information
contents (Figure 2D).
Among the 41 introns yielding the 181 clones, 14 introns
carried multiple branch sites. In eight of the 14 introns
(57%), the most downstream branch sites were most
frequently used (Table 3). Although the ratio of 57% was
not high, the downstream branch sites were four to eight
times more frequently used than the upstream sites in four
of the eight introns. We could not observe this magnitude
of diﬀerential branch site usage in the remaining six
introns, in which the downstream branch points were not
overrepresented. Accordingly, when there are multiple
branch points, downstream branch points are more likely
to be employed than their upstream counterparts.
We also predicted BPSs of our housekeeping genes with
the Branch Site Analyzer (14), and found that the actual
branch sites matched to the predicted positions in 80 of
the 181 sites (44.2%) (Table 3).
Alignment of polypyrimidine tractin respect
to thebranchpoint
We next aligned the PPT’s in respect to the 181 branch
points (Figure 3B and C). We observed a polypyrimidine
stretch from position +4 down to position +24. The ‘U’
nucleotide was preferred over ‘C’ especially at positions
+4 to +12 in the PPT. Alignment of the PPT in respect to
the 30 end of an intron also demonstrated a stretch of
pyrimidines from positions  20 to  4 (Figure 3D and E).
Figure 2. Pictogram (A, C and E) and WebLogo (B, D and F)
presentations of mammalian BPSs. (A and B) Twenty-nine mammalian
and viral BPSs identiﬁed by in vitro experiments (Table 2). (C and D)
BPSs with a misincorporated nucleotide at the branch point in our
studies. (E and F) BPSs without a misincorporated nucleotide at the
branch point in our studies. We assume that ‘A’ residue one or two
nucleotides downstream of the sequenced branch point is the actual
branch point (see Figure 1B). Position 0 represents the branch point.
2260 Nucleic Acids Research, 2008, Vol. 36, No. 7Figure 3. (A) Positions and nucleotides of 181 branch points with misincorporated nucleotides in our studies, where position  1 represents the 30 end
of an intron. The median value of the branch points is  26, and the mean and SD is  27.7 7.6. Among the 181 sites with misincorporated
nucleotides at the branch points, 150 sites (83%) are at positions  34 to  21 (horizontal bar on top). Native nucleotides, not the misincorporated
nucleotides, are indicated. Nucleotide preferences (B and D) and information contents (C and E) are deduced from 181 branch points. (B and C)
Plots are aligned in respect to the branch point (closed arrows), which is designated as position 0. Open arrows point to peaks of information
contents at positions +7 and +8. A polypyrimidine stretch starts from position +4 down to position +24 (bars). The plots are truncated at
position +25, because the numbers of observations fall below 40 after position +25, and the plots become less informative and uneven. The last
three nucleotides of introns are excluded from the plots. (D and E) Plots are aligned in respect to the 30 end of each intron, which is designated as
position  1. A polypyrimidine stretch spans positions  19 to  5 (bars).
Figure 4. Representative composition of the branch point sequence (arrow) and the PPT deduced from our studies.
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Gene Intron Intron
size (bp)
Predicted
BP
a
BPS
Score
a
Observed
BP
Number of
clones
Misincorporated
nucleotide
Intronic sequence from BPS position  5t ot h e
30 end of an intron
b
ACTB 3 441  24A 3.10  30A 10 – TCCCCAGTGTGACATGGTGTATCTCTGCCTTACAG
ALOD 8 984  24A 3.05  26T 2 – TGTCTTAATGTTGTTACCCTGACCCCAACAG
 25A 2 T GTCTTAATGTTGTTACCCTGACCCCAACAG
 5A 1 – ACCCCAACAG
CCT3 4 1069  21A 3.30  32A 3 – TGAATAGTGTGAATTCACTAGTGATCTACC
TTTTTAG
 30T 1 – AATAGTGTGAATTCACTAGTGATCTACCTTTTTAG
 21A 2 T AATTCACTAGTGATCTACCTTTTTAG
CCT3 11 845  44A 2.95  24A 6 T GCTTCATACTGTCTGTTTGCTTCTCCAAG
 10C 1 – GTTTGCTTCTCCAAG
EEF1A1 2 366  24A 2.80  28A 2 T TAGTAACCAAGTAACGACTCTTAATCCTTACAG
 19C 1 – AGTAACGACTCTTAATCCTTACAG
EEF1A1 1 943  33A 3.25  23A 10 T GGTTCAAAGTTTTTTTCTTCCATTTCAG
ENO1 2 2837  33A 3.25  27T 6 – ATTGCTACTACATCTTTTTTCCTCTCATCCAG
 25C 2 T TGCTACTACATCTTTTTTCCTCTCATCCAG
ENO1 4 2394  21A 3.45  21A 10 T CCCTCATTCTCCCCTCTCCCTCGTAG
ENO1 5 737  32A 3.20  27A 6 T ACTTCATTCCACTCGGTTCTCTTCTGTTCTAG
 24C 1 – TCATTCCACTCGGTTCTCTTCTGTTCTAG
ENO1 6 615  36A 2.85  30T 2 G CCCAGTGCCATGCTTCTCTGCTCTGCTCTCCCCAG
 27C 3 A AGTGCCATGCTTCTCTGCTCTGCTCTCCCCAG
 26A 3 – GTGCCATGCTTCTCTGCTCTGCTCTCCCCAG
ENO1 7 796  25A 3.05  38A 3 T TACCTACCTGTTTTCCAAACCTGTTGTCACCATC
TCTTCCCAG
 28C 1 – TTTTCCAAACCTGTTGTCACCATCTCTTCCCAG
 27A 2 T TTTCCAAACCTGTTGTCACCATCTCTTCCCAG
 26A 2 T TTCCAAACCTGTTGTCACCATCTCTTCCCAG
ENO1 9 547  30A 2.70  5T 2 A TGGCTTCCAG
ENO1 11 1457  26A 2.95  48T 4 – AGGTCTGACTTTTCTTTTTTCCTCCCCATCTCTTTACC
TTTCTCCTTCCCAAG
 47G 2 – GGTCTGACTTTTCTTTTTTCCTCCCCATCTCTTT
ACCTTTCTCCTTCCCAAG
 46A 3 T GTCTGACTTTTCTTTTTTCCTCCCCATCTCTTTACC
TTTCTCCTTCCCAAG
G22P1 1 6031  28A 2.90  30A 2 – AGGACAAACATTTTCTTCCATTTTTTTCCCCATAG
 28A 4 T GACAAACATTTTCTTCCATTTTTTTCCCCATAG
G22P1 8 3212  26A 2.50  31A 2 – AAGTCAAATCAAAGAAAATTTATCTCCTTTCTTCAG
 26A 1 T AAATCAAAGAAAATTTATCTCCTTTCTTCAG
 25A 1 T AATCAAAGAAAATTTATCTCCTTTCTTCAG
G22P1 10 2978  33A 3.60  33A 10 – GACTCACCAGGCCACTCTTCTGTGTTTTGATTT
TCTAG
GAPDH 2 1633  26A 3.35  6T 10 – TTGTCTCTTAG
HSPA8 1 734  39A 3.15  23A 1 T TTTTAAACCAGATTTTTCTTTTTTTCAG
 19A 1 – AAACCAGATTTTTCTTTTTTTCAG
 17A 1 C ACCAGATTTTTCTTTTTTTCAG
HSPCB 6 448  18A 3.15  22A 6 T GTACCACTTATTTTTGGTTTCTTTCAG
 23C 1 – TGTACCACTTATTTTTGGTTTCTTTCAG
HSPCB 10 777  22A 3.20  24T 1 – CAATCTAAGGCTTTTGTGATCGTCCACAG
 22A 2 T ATCTAAGGCTTTTGTGATCGTCCACAG
HSPCB 1 1434  22A 2.75  18A 1 T AATTAATGAGATTTTTATTTTAG
LDHB 2 7526  22A 3.35  24T 4 – GGTTCTAATGCCTGTTTTTGCGTTTACAG
 23A 1 T GTTCTAATGCCTGTTTTTGCGTTTACAG
 22A 6 T TTCTAATGCCTGTTTTTGCGTTTACAG
PGK1 1 5461  28A 3.00  29G 2 – AAGTTGATCATGGTCTTGCATCTTTCTTTTTTAG
 28A 4 T AGTTGATCATGGTCTTGCATCTTTCTTTTTTAG
PGK1 2 3826  35A 3.00  26T 4 – CATTCTGTTTGTTGTCTCTCTTTGGTTGCAG
PGK1 4 3151  29A 3.35  33C 1 – GGAGCCATCACATTTTCTGTTTTTGTTTTTCTCTA
TAG
 29A 5 T CCATCACATTTTCTGTTTTTGTTTTTCTCTATAG
PGK1 5 635  32A 3.40  29A 1 T TGACTAGAATCTGAATGTCTTTGATCTTTTCTAG
(Continued)
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Gene Intron Intron
size (bp)
Predicted
BP
a
BPS
Score
a
Observed
BP
Number of
clones
Misincorporated
nucleotide
Intronic sequence from BPS position  5 to the
30 end of an intron
b
 22G 7 – AATCTGAATGTCTTTGATCTTTTCTAG
 21A 2 T ATCTGAATGTCTTTGATCTTTTCTAG
PGK1 6 4664  27A 3.15  28A 1 T TCTTTAAGTGATGATTCTTGCTTTCTCTTGTAG
 23A 8 T AAGTGATGATTCTTGCTTTCTCTTGTAG
PGK1 8 1499  27A 3.20  27A 10 T AGCTCATCTTCTCTTTCACCTCTACCCCTCAG
PGK1 10 364  35A 2.75  36A 10 – ATAGTAATGCTGTCTATGTATGTGTGCTCTCTC
AAAAACAG
PKM2 2 1443  39A 3.05  31A 2 T AATTAATACTTGTGGCTTTAAAACTTTTCCTAATAG
 29A 1 T TTAATACTTGTGGCTTTAAAACTTTTCCTAATAG
 25G 1 C TACTTGTGGCTTTAAAACTTTTCCTAATAG
 23G 1 C CTTGTGGCTTTAAAACTTTTCCTAATAG
PKM2 3 6930  21A 2.75  25T 3 – ACGCTTGTCATCTTCCTTCTTTTCCCCCAG
 21A 4 T TTGTCATCTTCCTTCTTTTCCCCCAG
PKM2 4 487  26A 2.85  38T 1 – TGGTGTCTCCAGTTTGGACTCTTGCTTACTCTCTTGT
CCCTAG
 33A 1 T TCTCCAGTTTGGACTCTTGCTTACTCTCTTGTCC
CTAG
 23C 1 – GGACTCTTGCTTACTCTCTTGTCCCTAG
 16A 1 T TGCTTACTCTCTTGTCCCTAG
 8G 1 – CTCTTGTCCCTAG
 5C 1 – TTGTCCCTAG
PKM2 5 781 na na  32T 1 – CGTGCTCTGCCTCCCCTACTTACCCTTTTTCATACAG
 31C 1 – GTGCTCTGCCTCCCCTACTTACCCTTTTTCATACAG
 28C 3 – CTCTGCCTCCCCTACTTACCCTTTTTCATACAG
 20A 1 T CCCCTACTTACCCTTTTTCATACAG
 18T 1 A CCTACTTACCCTTTTTCATACAG
 16A 2 T TACTTACCCTTTTTCATACAG
PKM2 6 1343  29A 3.10  39G 1 C CCTCTGTTCTATATAACCTCTCTCCCCCCAACTTTG
TCCATCAG
 34A 6 T GTTCTATATAACCTCTCTCCCCCCAACTTTG
TCCATCAG
 32A 2 T TCTATATAACCTCTCTCCCCCCAACTTTGTCCATCAG
PKM2 8 4107 na na  65T 2 – CCTTTTGTGACAAAGCTCTGACAAAGCTCTGTCCC
CCTCTCGTCCCTCTGGACGGATGTTGCTCCCCTAG
 52T 1 – AGCTCTGACAAAGCTCTGTCCCCCTCTCGTCCCTC
TGGACGGATGTTGCTCCCCTAG
 50A 5 T CTCTGACAAAGCTCTGTCCCCCTCTCGTCCCTCTGGA
CGGATGTTGCTCCCCTAG
PKM2 10 717  25A 3.75  27T 1 – TTTACTCACCAACCTCCCTTCTCTTCCTCCAG
 26C 2 – TTACTCACCAACCTCCCTTCTCTTCCTCCAG
 25A 6 T TACTCACCAACCTCCCTTCTCTTCCTCCAG
PSMB4 4 393  40A 3.05  44A 4 T CTGTTATTCAGCCCAATATCCCCCCATGGTTTTCC
CCCAATCTCCCTAG
 40A 5 T TATTCAGCCCAATATCCCCCCATGGTTTTCCCCCA
ATCTCCCTAG
RPL13 4 583  21A 3.30  26A 1 C ACCCCACTTAACTCTTCTCATTCACCAACAG
 23T 1 – CCACTTAACTCTTCTCATTCACCAACAG
 22A 4 T CACTTAACTCTTCTCATTCACCAACAG
RPL13 5 492  22A 3.30  22A 9 – GTTTAACAACCTGTCTTTCTCTTCTAG
 20A 1 T TTAACAACCTGTCTTTCTCTTCTAG
RPL13A 1 2205  26A 3.55  22C 7 – GAGTCCTTTTGCCCTTGTCTCCCACAG
 8T 1 – TTGTCTCCCACAG
RPL3 2 770  21A 3.70  21A 4 T GTCTGACTACTGCTTTTTTTTTGCAG
 19T 3 – CTGACTACTGCTTTTTTTTTGCAG
RPL3 4 1150  22A 3.30  24T 10 – GGAGCTGAGCTGTGTCTACCTTCTCCTAG
RPL3 5 522  22A 2.50  29T 1 – GGCGCTGAGGTGAAGTAATGTGTATCCATTCCAG
RPL3 6 477  34A 3.45  22T 3 – AGCCTTACACCCTTCTTGTTCATTCAG
 21A 3 T GCCTTACACCCTTCTTGTTCATTCAG
RPL8 4 806 na na  23C 5 – GTTCCCTGAGGTATCTGATCCCCTACAG
SLC25A3 2 1591  30A 2.85  31A 1 – ATATTAAAATGCATGGTGTGTCTTCTCTTACTACAG
(Continued)
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between the two alignments. We observed peaks of infor-
mation contents seven and eight nucleotides downstream
of the branch point. The functional signiﬁcance of these
peaks, however, remains elusive.
Information obtainedfrom lariat RT-PCR clones without
misincorporated nucleotides
We next asked if we could exploit the 186 clones without
misincorporated nucleotides at the branch point. If there
was an ‘A’ nucleotide one or two nucleotides downstream
of the sequenced branch point and the sequenced branch
point was not ‘A’, we assumed that one or two nucleotides
were skipped by the reverse transcriptase and that the
particular downstream ‘A’ was the actual branch point.
A similar assumption has also been applied to three other
genes in previous reports (15–17). We aligned the branch
points under this assumption, and plotted the nucleotide
preferences and the information contents (Figure 2E
andF). Comparedtothoseofmisincorporatednucleotides,
the information contents were generally lower, but the
Pictogram and WebLogo presentations resulted in similar
patterns. These analyses suggest that one or two nucleo-
tides were skipped when there were no misincorporated
nucleotides, but deﬁnite experimental evidence is lacking to
employ these clones to deduce the human consensus BPS.
DISCUSSION
Highlydegenerative human BPS
We determined splicing branch points in 52 introns of
20 human housekeeping genes by lariat RT-PCR.
Our analysis disclosed the following features (Figure 4).
First, 83% of the branch points are located 21–34 nucleo-
tides upstream of the 30 end of an intron (Figure 3A).
Second, a polypyrimidine stretch spans 4–24 nucleotides
downstream of the branch point (Figure 3B and C). Third,
the human branch point consensus sequence is yUnAy
(Figure 2C and D). The ﬁrst and the second features
underscore the previous in silico observations (6,14),
whereas the degeneracy of the human BPS is more than
we have expected.
It is interesting to note that among the six consensus
BPSs proposed for the mammalian branch points
(Table 1), the shared nucleotides are yUnAy, which is
identical to that determined by our analysis.
SF1 binds to BPS using its KH domain (18). NMR
analysis of SF1 bound to the BPS revealed that a
hydrophobic motif of Gly-Pro-Arg-Gly within the KH
domain builds hydrogen bonds with ‘UAA’ at positions
 2 to 0 of the yeast BPS, ‘UACUAAC’ (19). Our analysis
suggests that the binding of the KH domain to position
 1 may enhance, but may be dispensable for, the recog-
nition of the BPS. Berglund and colleagues (20) also
demonstrate that, in ‘UACUAAC’ at positions  5 to +1,
nucleotide substitutions only at position  2o r0 ,
but not at the other positions, compromise the binding
of SF1.
Non-‘A’ nucleotidesat position 0
We observed an ‘A’ nucleotide at 92.3% of the branch
points. Non-‘A’ nucleotides at the branch point have
been reported in CALCA1 (21) and GH1 (22) (Table 2).
The two reports demonstrate six such examples in
Table 3. Continued
Gene Intron Intron
size (bp)
Predicted
BP
a
BPS
Score
a
Observed
BP
Number of
clones
Misincorporated
nucleotide
Intronic sequence from BPS position  5 to the
30 end of an intron
b
SNRPB 1 2929  24A 3.20  24A 1 T GTCTCATCCCTGTCCATTTCTCCTTGCAG
SNRPB 2 1787  34A 3.85  36T 2 – ACCTCTAACACTTTTTTTGTTCCTTCTAAAC
CTCTCTTTAG
 35A 5 – CCTCTAACACTTTTTTTGTTCCTTCTAAACC
TCTCTTTAG
 34A 2 T CTCTAACACTTTTTTTGTTCCTTCTAAAC
CTCTCTTTAG
SNRPB 3 1808  34A 3.10  30G 2 – CACTGGGCATCAGAGCATATTTGTTTATTT
TTCAG
 29G 3 – ACTGGGCATCAGAGCATATTTGTTTATTTT
TCAG
 28C 1 G CTGGGCATCAGAGCATATTTGTTTATTTTTCAG
 27A 2 – TGGGCATCAGAGCATATTTGTTTATTTTTCAG
SNRPB 4 519  25A 3.75  27T 7 – TCTTCTAACTCTTTCTTCTTATGTCCTCTTAG
 26A 1 T CTTCTAACTCTTTCTTCTTATGTCCTCTTAG
 25A 5 T TTCTAACTCTTTCTTCTTATGTCCTCTTAG
SNRPB 6 696  25A 3.95  27T 8 – GGCACTGACTAAACTTCTTACTCTTACTTCAG
UBB 1 717  33A 3.45  30T 6 – TGAGGTGACACGCTTATGTTTTACTTTTAAA
CTAG
 29G 1 – GAGGTGACACGCTTATGTTTTACTTTTAA
ACTAG
 28A 2 T AGGTGACACGCTTATGTTTTACTTTTAAACTAG
aPredicted BPs and BPS scores are according to the Branch-Site Analyzer at http://ast.bioinfo.tau.ac.il/BranchSite.htm (14).
bObserved branch sites are underlined.
2264 Nucleic Acids Research, 2008, Vol. 36, No. 7four introns. As these unusual branch points constitute
21% (6/29) of the previously reported in vitro determined
branch points, the ratio of ‘A’ at the branch point is
reduced to 79% (Table 2). Additionally, the potential
observation bias posed by these unusual BPSs may
account for the diﬀerences in the Pictogram and
WebLogo patterns between the previously identiﬁed
BPSs (Figure 2A and B) and our BPSs (Figure 2C and D).
Disease-causing mutationsdisrupting BPSs
According to the Human Gene Mutation Database (23),
splicing mutations account for 13.7% (1768 of 12 879) of
single nucleotide substitutions. Most splicing mutations,
however, are at the splice donor or acceptor sites. To our
knowledge, sixteen disease-causing mutations and a single
polymorphism disrupt BPSs and give rise to aberrant
splicings (Table 5). Nine variants are at position 0, and the
other eight are at position  2. Among the nine variants
aﬀecting position 0, seven are A-to-G mutations, which
supports the notion reported by Kralovicova and collea-
gues (24) that A-to-G transitions at position 0 are more
deleterious than A-to-T or A-to-C transversions. For all
the variants, aberrant splicings have been determined
either in patients or minigenes. The actual branch points,
however, have been identiﬁed only in two variants by
lariat RT-PCR, whereas the remaining fourteen variants
have been mapped to putative BPSs. Exclusive conﬁne-
ment of BPS-disrupting nucleotide changes at positions
 2 and 0 also underscores our observation that the BPS
consensus is yUnAy.
Conversely, mutations disrupting yUnAy are not
always deleterious. When the branch point ‘A’ is mutated
or deleted, a neighboring cryptic ‘A’ residue is employed
as a branch point (25–27), or the mutant ‘C’, ‘G’ or ‘U’
residue is used as a surrogate branch point (28).
Additionally, we observed two or more branch sites in
15 of 41 introns (Table 3), which also implies that a
mutation-harboring BPS can be readily substituted for by
another BPS.
How isthe highly degenerativeBPS recognized?
It is hard to believe that SF1 simply recognizes yUnAy.
We expect that SF1 recognizes the BPS along with the
other cis-element(s) and their interacting trans-factor(s).
The SELEX screening of the yeast BBP binding motifs
revealed a stem and loop structure immediately upstream
of the BPS of ‘UACUAAC’ in 9 out of 48 selected motifs
(29). A gel shift assay also showed preferential binding of
human SF1 to ‘UACUAAC’ carrying an upstream stem
and loop. Our BPSs, however, had no upstream stem and
loop structures (data not shown). An upstream stem and
loop may help recognize highly degenerative mammalian
BPSs for a subset of introns.
In the early step of the spliceosome assembly, SF1,
U2AF65 and U2AF35 bind to the BPS, the PPT and AG
at the 30 end of an intron, respectively, to form complex E
(1,2). In S. pombe, SF1/BBP is tightly associated with
U2AF59, a yeast homolog of mammalian U2AF65 reco-
gnizing the PPT, as well as with U2AF23, a yeast homolog
of mammalian U2AF35 recognizing the 30 AG (30).
Table 4. Nucleotide frequencies at the 181 branch sites
Position  5  4  3  2  10 1 2 3
A 0.254 0.232 0.083 0.066 0.166 0.923 0.182 0.302 0.201
C 0.210 0.227 0.470 0.160 0.448 0.033 0.331 0.274 0.391
G 0.254 0.193 0.127 0.028 0.177 0.017 0.066 0.112 0.112
U 0.282 0.348 0.320 0.746 0.210 0.028 0.420 0.313 0.296
Table 5. Sixteen mutations and a single polymorphism disrupting BPSs
Gene and intron Sequence Consequence Reference
LCAT intron4
Wild-type CCCTGAC
Mutant CCCCGAC Intron retention
a (43,44)
Mutant CCCGGAC Intron retention
b (45)
Mutant CCCAGAC Intron retention
b (45)
FBN2 intron30
Wild-type TACTAAG
Mutant TACGAAG Exon skipping
a (46)
COL5A1 intron32
Wild-type GACTGAC
Mutant GACGGAC Exon skipping
a (47)
ITGB4 intron31
Wild-type GGCTCAC
Mutant GGCACAC Intron retention,
a
cryptic 30 splice site
a
(48)
TH intron10
Wild-type GGCTGAT
Mutant GGCAGAT Exon skipping,
a
cryptic 30 splice site
a
(49)
L1CAM intron18
Wild-type ATCCAAG
Mutant ATCCACG cryptic 30 splice site
a (50)
LIPC intron1
Wild-type CCCCAAT
Mutant CCCCAGT cryptic 30 splice site
a (51)
FBN2 intron28
Wild-type TTGCAAT
Mutant TTGCAGT Exon skipping
a (52)
HEXB intron10
Wild-type TTGCAAT
Mutant TTGCAGT Cryptic 30 splice site
a (53)
NF2 intron5
Wild-type TTCTAGC
Mutant TTCTAAC Intron retention
a (54)
TSC2 intron38
Wild-type GCGTGAC
Mutant GCGTGGC Cryptic 30 splice site,
a
intron retention
a
(55)
XPC intron3
c
Wild-type TACTGAT
Mutant TACTGGT Exon skipping
a (16)
NPC1 intron6
Wild-type CACTAAT
Mutant CACTAGT Exon skipping
a (56)
F9 intron 2
Wild-type CGTTAAT
Mutant CGTTAGT Exon skipping
b (24,57)
DQB1 intron 3
c,d
Genotype A CACAGAC Exon skipping
b (17)
Genotype U CACUGAC Exon inclusion
b (17)
Mutations or a polymorphism are underlined.
Aberrant splicings have been determined in patients
a or minigenes
b.
cBranch points have been identiﬁed by lariat RT-PCR. Others are
putative BPSs lacking in vitro evidence.
dPolymorphism.
Nucleic Acids Research, 2008, Vol. 36, No. 7 2265In mammals, the association between SF1 and U2AF65 is
mediated by the 28 N-terminal amino acids of the KH
domain of SF1(31) and by the third RBD of U2AF65 (32).
Wang and colleagues determined that Ser20 in the N-
terminal region of the KH domain is essential for binding
to U2AF65 and that phosphorylation of Ser20 inhibits its
binding and formation of complex A (33). Berglund and
colleagues also report that the SF1-U2AF65 interaction
promotes cooperative binding to the BPS and the PPT
(32). Our analysis also demonstrates positional association
of the BPS and the PPT (Figure 3B and C). On the other
hand, Kent and colleagues demonstrate that U2AF65 and
U2AF35 are dispensable for the binding of SF1 to the BPS
(34). Sharma and colleagues similarly show that complex
H includes SF1 in the absence of U2AF65 and U2AF35
(35). Although the exact order of the SF1, U2AF65 and
U2AF35 assembly remains elusive, the BPS is possibly
recognized along with the PPT and the 30 AG.
Alternatively, SF1 is bound to any yUnAy sequences in
complex H, and a particular SF1 that successfully
associates with the U2AF heterodimer exclusively survives
to form complex E.
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